About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,811 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,811 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2441-2460 of 10,811 trials

CompletedA Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment PeriodThe main aim of this study is to show how well TAK-279 reduces the skin plaques compared to placebo, in participants with moderate-to-severe plaque psoriasis.NCT06108544·Birmingham, Alabama and 216 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

TerminatedStudy to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure ClustersThe purpose of this study is to examine the long-term safety and tolerability of USL261 in the treatment of seizure clusters.NCT01529034·Phoenix, Arizona and 57 others

TerminatedRenin-Angiotensin and Fibrinolysis in Humans: Effect of Long-Term PDE5 Inhibition on Glucose HomeostasisThe purpose of this study is to determine the effect of chronic PDE5 inhibitor therapy on glucose metabolism in persons with prediabetes.NCT01409993·Nashville, Tennessee

RecruitingStudy to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMDThe purpose of this study is to collect efficacy and safety information of intravitreal injection for 3 experimental arms, including 2 dose levels of ONL1204 and 2 treatment…NCT06659445·Gilbert, Arizona and 119 others

CompletedQuantitative Detection of Circulating Donor-Specific DNA in Organ Transplant Recipients (DTRT-Multi-Center Study)The primary goal of this Multicenter Study is to develop and to evaluate a method for measuring donor-specific cell free DNA in blood samples from transplant recipients as markers…NCT02109575·Little Rock, Arkansas and 7 others

Active not recruitingA Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 MonthsThe purpose of this study is to assess the safety and immunogenicity of mRNA-1365, an mRNA vaccine targeting respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) and…NCT05743881·Los Angeles, California and 16 others

CompletedUse of MRI and cTBS for Catatonia in AutismDespite the significant morbidity and mortality associated with catatonia in autism, no diagnostic research has attempted to identify biomarkers for catatonia.NCT06016764·Nashville, Tennessee

CompletedEcteinascidin 743 in Treating Children With Refractory Solid TumorsRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00006463·Little Rock, Arkansas and 46 others

TerminatedA Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced MalignanciesA Phase 1/2, open label, multi-center study to evaluate the safety, efficacy and tolerability of alomfilimab as single agent and in combination with anti-PD-L1 (atezolizumab) in…NCT03829501·Duarte, California and 21 others

CompletedAdalimumab vs. Conventional Immunosuppression for Uveitis TrialNon-infectious intermediate, posterior, and panuveitides are chronic, potentially-blinding diseases.NCT03828019·Los Angeles, California and 25 others

CompletedA Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 DiabetesThe purpose of this study is determine whether the combination of naltrexone SR and bupropion SR is safe and effective in treating obesity in subjects with type 2 diabetes.NCT00474630·Fairhope, Alabama and 52 others

RecruitingSymbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial CancerThis study is being done to learn more about a new medicine called PF-08634404.NCT07421700·Fayetteville, Arkansas and 172 others

CompletedTPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced CancersThis is a phase 1/1b open label, multicenter dose escalation and dose expansion study to investigate the safety, tolerability and anti-tumor activity of TPST-1120, a small…NCT03829436·San Francisco, California and 10 others

Active not recruitingStudy Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut.NCT04524611·Chandler, Arizona and 299 others

RecruitingA Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple MyelomaThe primary purpose of this study is to assess the efficacy (overall response rate) of subcutaneous (SC) via on body delivery system (SC-OBDS) isatuximab in combination with…NCT06356571·Phoenix, Arizona and 33 others

CompletedA Dose Ranging Study Of PF-00868554 In Combination With PEGASYS And COPEGUS In Patients With Chronic Hepatitis C Genotype 1 InfectionThe purpose of this study is to further assess the potency of PF-00868554, an HCV polymerase inhibitor, in subjects chronically infected with HCV by evaluating the antiviral…NCT00720434·La Jolla, California and 9 others

TerminatedA Study of AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate CarcinomaThis is a phase 1, open-label study evaluating the safety, clinical pharmacology and clinical activity of AMG 340, a PSMA x CD3 T-cell engaging bispecific antibody, in subjects…NCT04740034·San Francisco, California and 6 others

CompletedNasopharyngeal Versus Nasal Cannula Oxygen Supplementation in Surgery PatientsThe investigators plan to conduct a randomized, controlled trial comparing nasopharyngeal oxygen supplementation to traditional nasal cannula in patients undergoing oral surgery…NCT02219464·Nashville, Tennessee

CompletedAortic Valve Replacement With Trifecta(TM)To confirm the clinical safety and effectiveness of the Trifecta valve.NCT00475709·Los Angeles, California and 17 others

TerminatedTicagrelor in Severe Community Acquired PneumoniaThe purpose of this study is to determine if the drug ticagrelor will be an effective treatment for patients with severe community acquired pneumonia.NCT01998399·Tucson, Arizona and 25 others

PreviousPage 123 of 541Next

Diabetes

in Nashville

Heart Diseasein Nashville